Related Experiment Videos
Hereditary diffuse gastric cancer.
1Department of Biochemistry, University of Otago, Dunedin, New Zealand.
Advances in Cancer Research
|October 23, 2001
Summary
Hereditary diffuse gastric cancer (HDGC) is a genetic syndrome linked to E-cadherin gene mutations. Loss of E-cadherin promotes diffuse gastric cancer and may increase lobular breast cancer risk.
Area of Science:
- Oncology
- Genetics
- Cell Biology
Background:
- Hereditary diffuse gastric cancer (HDGC) is an inherited cancer predisposition syndrome.
- It is caused by germline mutations in the E-cadherin gene, which encodes a key cell-to-cell adhesion protein.
Purpose of the Study:
- To review identified families with HDGC.
- To summarize the mutations associated with HDGC.
- To discuss proposed mechanisms by which E-cadherin loss contributes to tumorigenesis.
Main Methods:
- Literature review of identified HDGC families and associated mutations.
- Analysis of proposed molecular mechanisms linking E-cadherin dysfunction to cancer development.
Main Results:
- HDGC is characterized by a strong predisposition to the diffuse, poorly differentiated subtype of gastric cancer.
- The syndrome is not associated with intestinal-type gastric cancer.
- An elevated risk of lobular breast cancer is observed in some HDGC families.
Conclusions:
- Germline E-cadherin mutations are the primary cause of HDGC.
- E-cadherin dysfunction plays a critical role in the pathogenesis of diffuse gastric cancer.
- Understanding these mechanisms may inform future therapeutic strategies for HDGC and related cancers.